Research and Development GB

Research and Development

Our Research and Development (R&D) efforts are dedicated to creating new and innovative pharmaceuticals for the treatment of psychiatric and neurological disorders. Through investment and perseverance, we strive to create the very best treatments for patients.  

We are the only fully-integrated pharmaceutical company in the world, solely devoted to the treatment of psychiatric and neurological disorders. We dedicate our entire R&D efforts to develop innovative drugs for treatment of a number of psychiatric and neurological disorders. Our R&D projects focus on: Alzheimer’s disease, Depression, Parkinson’s disease, and Schizophrenia.  

Search results for "". Page 1 of 1, Results 1 to 6 of 6
Title Location Country
Reset
Regulatory Scientist - Regulatory Dossier Management
Regulatory Scientist - Regulatory Dossier Management Copenhagen, Danish Capital Region, DK 11 Jun 2024 0.00 km
Copenhagen, Danish Capital Region, DK Denmark
Director, Qualified Person (QP) for IMP
Director, Qualified Person (QP) for IMP Copenhagen, Danish Capital Region, DK 8 Jun 2024 0.00 km
Copenhagen, Danish Capital Region, DK Denmark
Senior Regulatory Publisher
Senior Regulatory Publisher Copenhagen, Danish Capital Region, DK 30 May 2024 0.00 km
Copenhagen, Danish Capital Region, DK Denmark
QPPV Office Professional
QPPV Office Professional Copenhagen, Danish Capital Region, DK 27 May 2024 0.00 km
Copenhagen, Danish Capital Region, DK Denmark
QP delegate Biologics, CMC
QP delegate Biologics, CMC Copenhagen, N/A, DK 27 May 2024 0.00 km
Copenhagen, N/A, DK Denmark
Pharmacokineticist, PK/PD Modelling & Simulation
Pharmacokineticist, PK/PD Modelling & Simulation Copenhagen, Danish Capital Region, DK 22 May 2024 0.00 km
Copenhagen, Danish Capital Region, DK Denmark